| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $3.08 | - | - |
| Q1'26 | $1.31 | $2.95 | +124.6% |
| Q4'25 | $0.10 | $-0.53 | -621.0% |
| Q3'25 | $-0.88 | $-0.19 | +78.3% |
| Q2'25 | $-0.81 | $0.11 | +113.5% |
| Q1'25 | $-0.68 | $-0.18 | +73.5% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $1.6B | - | - |
| Q1'26 | $1.3B | $1.4B | +8.5% |
| Q4'25 | $1.4B | $1.4B | +5.7% |
| Q3'25 | - | $1.3B | - |
| Q2'25 | - | $1.3B | - |
| Q1'25 | - | $1.1B | - |
Market Data
ALB is currently trading at $126.18, giving Albemarle Corporation a market cap of 14.95B. Today's range spans $125.92–$129.10, with shares opening at $128.99 and moving up $0.12 (0.1%) from the prior close. DailyIQ's technical score sits at 27/100 (SELL) with a news sentiment reading of 51/100.
Over the past year ALB has traded between $64.95 and $221.00 - the current price is +94.3% off the 52-week low and -42.9% from the high. 30 analysts cover the stock with a Buy consensus and a mean 12-month target of $204.46 (range $83.28–$260.00), implying upside of +62.0%.
Albemarle Corporation (ALB) is at $126.18 (in the lower half of its 52-week range in $64.95–$221.00), carrying a SELL signal (27/100) and neutral sentiment (51/100). The 14.95B market cap in Basic Materials means this name is well-covered by analysts who can accelerate the downside through rating cuts and target reductions - a feedback loop that smaller stocks with less coverage don't face to the same degree.
When a large-cap Basic Materials name with 14.95B in capitalization prints a SELL signal (27/100) alongside neutral news sentiment (51/100), the risk isn't just price depreciation — it's the loss of institutional sponsorship that makes recovery harder. At $126.18 (in the lower half of its 52-week range in the $64.95–$221.00 range), the structural support levels are where that sponsorship question gets answered.
Sentiment gathered from recent headlines
Most recent articles, ranked by recency (click to expand).